Page de couverture de The Lancet Respiratory Medicine in conversation with

The Lancet Respiratory Medicine in conversation with

The Lancet Respiratory Medicine in conversation with

Auteur(s): The Lancet Group
Écouter gratuitement

À propos de cet audio

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

© 2025 The Lancet Group Hygiène et mode de vie sain Science Sciences biologiques Troubles et maladies
Épisodes
  • Joan Soriano on Global Epidemiology of Respiratory Disease

    Joan Soriano on Global Epidemiology of Respiratory Disease
    Jul 17 2025

    Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challenges, global trends, and future directions for prevention.

    Read the full Series:

    https://www.thelancet.com/series-do/global-epidemiology-chronic-respiratory-disease?dgcid=buzzsprout_icw_podcast_lanrescrd25_lanres

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Voir plus Voir moins
    11 min
  • Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

    Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial
    Jul 16 2025

    Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat TB in individuals with pre-extensively drug-resistant tuberculosis.

    Read the full article:

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Voir plus Voir moins
    19 min
  • Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

    Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)
    Jul 16 2025

    This episode is in Italian. For the English version, please see the main feed.

    Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui con tubercolosi pre-estesa farmaco-resistente.

    Leggi l'articolo completo:

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Voir plus Voir moins
    15 min

Ce que les auditeurs disent de The Lancet Respiratory Medicine in conversation with

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.